by Chris Lee | Jun 5, 2016 | Stock Analysis / Investing
Keryx Biopharmaceuticals (NASDAQ: KERX) As Part Of My Portfolio KERX is one of the more interesting stock in my portfolio– and it is also a growth stock that has the potential to be a multi-bagger. What is a multi-bagger? “A multibagger is an investment... 
by Chris Lee | May 18, 2016 | Stock Analysis / Investing
I am a fan of George Clooney. The latest movie that he acted in is called Money Monster. This article aims to share what I have learnt from watching the movie– from the perspective of someone who love investing. Before I share with you the lessons that I learnt,... 
by Chris Lee | May 15, 2016 | Uncategorized (old)
Past Equal To Future? We have to take note that since expected returns we expect to receive from a stock investment is based on assumptions using past returns, we are basing the assumption that the past would equal to the future. This assumption would not be relevant... 
by Chris Lee | May 6, 2016 | Popular
One of the first stock that I bought was called iShares Nasdaq Biotechnology ETF (NASDAQ: IBB). I bought it on 5th February 2015 at $310.51 and sold it on 13th July 2015 at $380, netting a cool 21.39%. I like biotechnology stock and so far I have had good experience... 
by Chris Lee | May 2, 2016 | Uncategorized (old)
7 Offline Channels for leads and their real cost So much ado has been made about leads and their real cost. But what are the channels that you, the business owner or salesperson, can use to get more leads? The role of face-to-face event prospecting is in the business...